Literature DB >> 10602010

A role for lymphotoxin beta receptor in host defense against Mycobacterium bovis BCG infection.

R Lucas1, F Tacchini-Cottier, R Guler, D Vesin, S Jemelin, M L Olleros, G Marchal, J L Browning, P Vassalli, I Garcia.   

Abstract

To investigate the role of membrane lymphotoxin (LT)alpha1 / beta2 and its LTbeta receptor (LTbetaR) in the protective immune response to Mycobacterium bovis bacillus Calmette-Guérin (BCG) infection, we have used a soluble fusion molecule (LTbetaR-IgG1). LTbetaR-Ig treatment interferes with granuloma formation mainly in the spleen by inhibiting macrophage activation and nitric oxide synthase activity. In addition, a large accumulation of eosinophils was observed in the spleen of LTbetaR-Ig-treated infected mice. Decreased blood levels of IFN-gamma and increased IL-4 were also observed, suggesting that the LTbetaR pathway is important in BCG infection to favor a Th1 type of immune response. The treatment of transgenic mice expressing high blood levels of a soluble TNFR1-IgG3 fusion protein with LTbetaR-Ig resulted in a still higher sensitivity to BCG infection, and extensive necrosis in the spleen. In conclusion, these results suggest that the LTbetaR and the TNFR pathways are not redundant in the course of BCG infection and protective granuloma formation: the LTbetaR pathway appears to be important in spleen granuloma formation, whereas the TNFR pathway has a predominant role in other tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602010     DOI: 10.1002/(SICI)1521-4141(199912)29:12<4002::AID-IMMU4002>3.0.CO;2-S

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Authors:  Thomas W Spahn; Hans-Pietro Eugster; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 2.  LIGHT-related molecular network in the regulation of innate and adaptive immunity.

Authors:  Yanhui Xu; Koji Tamada; Lieping Chen
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 4.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

5.  Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes.

Authors:  M Abolhassani; M Lagranderie; P Chavarot; A M Balazuc; G Marchal
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.

Authors:  Reto Guler; Maria L Olleros; Dominique Vesin; Roumen Parapanov; Irene Garcia
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Increased resistance to mycobacterial infection in the absence of interleukin-10.

Authors:  M Jacobs; N Brown; N Allie; R Gulert; B Ryffel
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

8.  Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.

Authors:  Reza Chakour; Reto Guler; Mélanie Bugnon; Cindy Allenbach; Irène Garcia; Jacques Mauël; Jacques Louis; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.

Authors:  Maria L Olleros; Dominique Vesin; Eduardo Martinez-Soria; Cindy Allenbach; Fabienne Tacchini-Cottier; Jean-Claude Pache; Gilles Marchal; Jubayer Rahman; Carmen Fernández; Shozo Izui; Irene Garcia
Journal:  Immunology       Date:  2007-07-09       Impact factor: 7.397

10.  Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.

Authors:  Nasiema Allie; Lena Alexopoulou; Valerie J F Quesniaux; Lizette Fick; Ksanthi Kranidioti; George Kollias; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunology       Date:  2008-06-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.